Cocrystal Pharma, Inc.
COCP
$1.24
$0.065.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -53.33% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -53.33% | -- | |||
| Cost of Revenue | 56.24% | -15.32% | |||
| Gross Profit | -77.75% | 29.22% | |||
| SG&A Expenses | -5.21% | 40.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.43% | 4.03% | |||
| Operating Income | -35.14% | 5.04% | |||
| Income Before Tax | -37.63% | 5.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -37.63% | 5.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.63% | 5.23% | |||
| EBIT | -35.14% | 5.04% | |||
| EBITDA | -35.32% | 5.02% | |||
| EPS Basic | -37.59% | 5.01% | |||
| Normalized Basic EPS | -37.62% | 5.10% | |||
| EPS Diluted | -37.59% | 5.01% | |||
| Normalized Diluted EPS | -37.62% | 5.10% | |||
| Average Basic Shares Outstanding | 0.01% | -0.20% | |||
| Average Diluted Shares Outstanding | 0.01% | -0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||